Amgen

FDA Panel Resoundingly Backs Amgen's Biosimilar Humira
Investors.com
Tue, 07/12/16 - 07:03 pm
FDA
advisory panels
Amgen
biosimilars
Humira
ABP 501
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
FDA
advisory panels
Humira
Enbrel
biosimilars
ABP-501
Amgen
AbbVie
GP2015
Novartis
FDA Approves First And Only Single Monthly Injection For A PCSK9 Inhibitor
Yahoo
Mon, 07/11/16 - 10:53 am
FDA
Amgen
Repatha
Repatha Pushtronex
PCSK9 inhibitors
Amgen drug appears 'highly similar' to Humira -FDA staff
Yahoo/Reuters
Fri, 07/8/16 - 10:23 am
Amgen
Humira
FDA
Enbrel
rheumatoid arthritis
ABP 501
biosimilars
Pfizer, Amgen, Regeneron Pharmaceuticals: How the PCSK9 Market is Evolving
Bidness, ETC
Thu, 07/7/16 - 03:41 pm
Pfizer
Amgen
Regeneron
PCSK9 inhibitors
Repatha
Praluent
Why Pfizer Inc, Amgen, Inc. are Just as Fitting for Medivation Inc as Sanofi
Bidness, ETC
Tue, 07/5/16 - 10:00 am
Pfizer
Amgen
Medivation
Sanofi
M&A
Biotech: What's Ahead For The Second Half Of 2016
Seeking Alpha
Tue, 07/5/16 - 09:57 am
biotech
AbbVie
Amgen
Allergan
Anacor
Gilead Sciences
Medivation
Pfizer
Sanofi
Pfizer's bococizumab may hit the PCSK9 market just in time
Fierce Pharma
Thu, 06/30/16 - 09:32 am
Pfizer
bococizumab
PCSK9 inhibitors
Amgen
Sanofi
Regeneron
Amgen, Inc. Fits Into Pfizer’s Restructuring Plans Perfectly
Bidness, ETC
Fri, 06/24/16 - 04:09 pm
Amgen
Pfizer
restructuring
M&A
Amgen, Novartis Court Case May Ease US Launch of Biosimilars
Bidness, ETC
Thu, 06/23/16 - 09:56 am
Amgen
Novartis
biosimilars
Zarxio
Supreme Court
2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't
Motley Fool
Sat, 06/18/16 - 02:24 pm
biotech
Amgen
Gilead Sciences
PDL Biopharma
Amgen, Inc. can Force Praluent Off Market but Regeneron Pharmaceuticals Inc May Still Be OK
Bidness, ETC
Thu, 06/16/16 - 03:22 pm
Amgen
Sanofi
Regeneron
Praluent
Repatha
patents
PCSK9 inhibitors
These 6 Drugmakers Could Be The Next Price War Casualties
Investors.com
Fri, 06/10/16 - 04:20 pm
drug pricing
Amgen
Gilead Sciences
Celgene
Biogen
Vertex Pharmaceuticals
Mylan
Biotech Stocks: Much Ado About Nothing at ASCO?
Barron's
Mon, 06/6/16 - 11:30 pm
ASCO 2016
biotech
Celgene
Amgen
Regeneron
Gilead Sciences
Amgen Gets CHMP's Positive Opinion To Extend Indication Of Kyprolis For Relapsed Multiple Myeloma Treatment
Yahoo/Benzinga
Fri, 05/27/16 - 10:43 pm
Amgen
CHMP
Kyprolis
Multiple Myeloma
Novartis, Amgen to See Higher Sales of New Heart Drugs
Bidness, ETC
Sat, 05/21/16 - 12:22 pm
Novartis
Amgen
Entresto
Corlanor
heart failure
Can Amgen’s Prolia Continue Its Strong Growth Trajectory in 2016?
Yahoo/Market Realist
Thu, 05/19/16 - 03:29 pm
Amgen
Prolia
Amgen Researchers Find Gene That Reduces Heart Attack Risk
Forbes
Thu, 05/19/16 - 09:40 am
Amgen
R&D
heart attack
deCODE Genetics
Behind Amgen’s Plans to Penetrate the Migraine Segment
Yahoo/Market Realist
Wed, 05/18/16 - 04:31 pm
Amgen
migraines
AMG 334
AMG 301
Novartis
Drug makers fuming at ‘overpriced’ values placed on their myeloma drugs
Stat
Mon, 05/16/16 - 03:55 pm
Multiple Myeloma
Amgen
Kyprolis

Pages